Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts
Pfizer (NYSE: PFE) has announced a conference call with investment analysts scheduled for October 29, 2024, at 10:00 a.m. EDT. The call aims to provide an update on Pfizer's Third Quarter 2024 Performance Report, which will be released that morning. Investors and the public can access the webcast and report at www.pfizer.com/investors.
Participants can join via webcast or by dialing 800-456-4352 (US/Canada) or 785-424-1086 (international) with passcode '72940'. A transcript and replay will be available on Pfizer's website within 24 hours after the call, accessible for at least 90 days.
Pfizer, a leading biopharmaceutical company, focuses on developing innovative medicines and vaccines to improve lives globally. With a 175-year history, Pfizer collaborates with healthcare providers and communities to advance wellness and expand access to affordable healthcare worldwide.
Pfizer (NYSE: PFE) ha annunciato una call con analisti finanziari programmata per il 29 ottobre 2024, alle 10:00 EDT. La chiamata ha lo scopo di fornire un aggiornamento sul Rapporto sulle Performance del Terzo Trimestre 2024 di Pfizer, che sarà reso pubblico quella mattina. Gli investitori e il pubblico possono accedere al webcast e al rapporto su www.pfizer.com/investors.
I partecipanti possono unirsi tramite webcast o chiamando il numero 800-456-4352 (US/Canada) oppure 785-424-1086 (internazionale) usando il codice di accesso '72940'. Una trascrizione e una registrazione saranno disponibili sul sito web di Pfizer entro 24 ore dopo la chiamata, accessibili per almeno 90 giorni.
Pfizer, una delle principali aziende biofarmaceutiche, si concentra sullo sviluppo di medicinali e vaccini innovativi per migliorare la vita a livello globale. Con una storia di 175 anni, Pfizer collabora con fornitori di assistenza sanitaria e comunità per promuovere il benessere e ampliare l'accesso a cure sanitarie accessibili in tutto il mondo.
Pfizer (NYSE: PFE) ha anunciado una conferencia telefónica con analistas de inversión programada para el 29 de octubre de 2024, a las 10:00 a.m. EDT. La llamada tiene como objetivo proporcionar una actualización sobre el Informe de Desempeño del Tercer Trimestre de 2024 de Pfizer, que se publicará esa mañana. Los inversores y el público pueden acceder al webcast y al informe en www.pfizer.com/investors.
Los participantes pueden unirse a través del webcast o llamando al 800-456-4352 (EE.UU./Canadá) o al 785-424-1086 (internacional) con el código de acceso '72940'. Una transcripción y una grabación estarán disponibles en el sitio web de Pfizer dentro de las 24 horas posteriores a la llamada, accesibles durante al menos 90 días.
Pfizer, una de las principales empresas biofarmacéuticas, se centra en desarrollar medicamentos y vacunas innovadores para mejorar la vida a nivel mundial. Con una historia de 175 años, Pfizer colabora con proveedores de atención médica y comunidades para promover el bienestar y ampliar el acceso a atención médica asequible en todo el mundo.
Pfizer(파이저, NYSE: PFE)는 투자 분석가와의 전화 회의를 2024년 10월 29일 오전 10:00 EDT로 예정했다고 발표했습니다. 이 통화는 그날 아침에 발표될 2024년 3분기 성과 보고서에 대한 업데이트를 제공하는 것을 목표로 합니다. 투자자와 일반 대중은 www.pfizer.com/investors에서 웹캐스트와 보고서에 액세스할 수 있습니다.
참여자는 웹캐스트 또는 800-456-4352 (미국/캐나다) 또는 785-424-1086 (국제)로 호출하여 비밀번호 '72940'을 사용하여 참여할 수 있습니다. 통화 후 24시간 이내에 Pfizer의 웹사이트에서 스크립트 및 다시 보기 기능이 제공되며, 최소 90일 동안 접근할 수 있습니다.
Pfizer는 전 세계적으로 생명을 개선하기 위해 혁신적인 의약품과 백신을 개발하는 데 중점을 둔 선도적인 생명공학 회사입니다. 175년의 역사를 가진 Pfizer는 헬스케어 제공자 및 커뮤니티와 협력하여 웰빙을 증진하고 전 세계의 저렴한 의료에 대한 접근성을 확대하고 있습니다.
Pfizer (NYSE: PFE) a annoncé une conférence téléphonique avec des analystes financiers prévue pour le 29 octobre 2024 à 10h00 EDT. L'appel vise à fournir une mise à jour sur le Rapport de Performance du Troisième Trimestre 2024 de Pfizer, qui sera publié ce matin-là. Les investisseurs et le public peuvent accéder au webcast et au rapport sur www.pfizer.com/investors.
Les participants peuvent rejoindre par webcast ou en appelant le 800-456-4352 (États-Unis/Canada) ou le 785-424-1086 (international) en utilisant le code d'accès '72940'. Une transcription et une rediffusion seront disponibles sur le site de Pfizer dans les 24 heures suivant l'appel, accessibles pendant au moins 90 jours.
Pfizer, une entreprise biopharmaceutique de premier plan, se concentre sur le développement de médicaments et de vaccins innovants pour améliorer la vie à l'échelle mondiale. Forte de 175 ans d'histoire, Pfizer collabore avec des prestataires de soins de santé et des communautés pour promouvoir le bien-être et élargir l'accès à des soins de santé abordables dans le monde entier.
Pfizer (NYSE: PFE) hat einen Konferenzanruf mit Investmentanalysten für den 29. Oktober 2024 um 10:00 Uhr EDT angekündigt. Ziel des Anrufs ist es, ein Update zum Leistungsbericht für das dritte Quartal 2024 von Pfizer zu geben, der an diesem Morgen veröffentlicht wird. Investoren und die Öffentlichkeit können über www.pfizer.com/investors auf das Webcast und den Bericht zugreifen.
Teilnehmer können sich über das Webcast oder unter 800-456-4352 (USA/Kanada) bzw. 785-424-1086 (international) mit dem Zugangscode '72940' einwählen. Ein Transkript und eine Aufzeichnung werden innerhalb von 24 Stunden nach dem Anruf auf der Pfizer-Website verfügbar sein und sind mindestens 90 Tage lang zugänglich.
Pfizer, ein führendes biopharmazeutisches Unternehmen, konzentriert sich auf die Entwicklung innovativer Medikamente und Impfstoffe zur Verbesserung der globalen Lebensqualität. Mit einer 175-jährigen Geschichte arbeitet Pfizer mit Gesundheitsdienstleistern und Gemeinschaften zusammen, um das Wohlbefinden zu fördern und den Zugang zu erschwinglicher Gesundheitsversorgung weltweit zu erweitern.
- None.
- None.
To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance of the conference call.
You can also listen to the conference call by dialing either 800-456-4352 in
The transcript and webcast replay of the call will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live conference call and will be accessible for at least 90 days.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, including financial guidance and projections, reorganizations, business plans, strategy and prospects; our Environmental, Social and Governance (ESG) priorities, strategy and goals; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities; and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the
The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.
Category: Finance
View source version on businesswire.com: https://www.businesswire.com/news/home/20240917734330/en/
Media Contact:
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor Contact:
IR@Pfizer.com
+1 (212) 733-4848
Source: Pfizer Inc.
FAQ
When is Pfizer's (PFE) Q3 2024 earnings call scheduled?
How can investors access Pfizer's (PFE) Q3 2024 earnings call?
Where can I find Pfizer's (PFE) Q3 2024 Performance Report?
How long will Pfizer's (PFE) Q3 2024 earnings call replay be available?
What is the main focus of Pfizer's (PFE) business?
